Which hedge funds own TRDA? ENTRADA THERAPEUTICS INC, Q2 2026 13F holders
HealthcareBiotechnologyFollow
26 tracked hedge funds disclosed a position in TRDA (ENTRADA THERAPEUTICS INC) in their Q2 2026 13F filings, worth $107.0m in total. The largest holder by portfolio weight is 5AM Venture Management, LLC at 10.4% of its book. 8 opened a new position this quarter: MPM Bioimpact LLC, Verdad Advisers, LP, Gsa Capital Partners LLP, Graham Capital Management, L.P.. 2 exited: Jones Hill Capital LP, Marshall Wace, LLP.
26
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
8
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
2
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$11.0m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$5.4m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$107m
Combined value
Sum of the holders' reported positions in the security.
2.1%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.